VINCIARELLI PATRIZIO sold $7.1M of VICR

VINCIARELLI PATRIZIO (Chairman & CEO) sold 20,000 shares of VICOR CORP (VICR) at an average of $356.68 ($345.02–$366.70, $7.13M total) across 19 trades on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jul 6, 2026, 3:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 6, 2026, 3:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The disclosure can influence short-term sentiment, but the presence of a 10b5-1 plan generally lowers the probability that the sale signals new negative information.

02

Market read

A $7.13M CEO/Chairman sale under 10b5-1 is a modest sentiment input rather than a fundamental catalyst.

03

What to watch

Traders may over-weight the sale size; the key is whether additional filings show continued clustered selling beyond the planned schedule.

Relevance 5/10Novelty 6/10Timing: today’s SEC Form 4 filing (covering trades dated 2026-07-01)

Background

The article is an SEC Form 4 insider transaction: CEO/Chairman VINCIARELLI PATRIZIO sold VICR shares in multiple trades on 2026-07-01; the filing was made 2026-07-06.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR’s CEO/Chairman sold 20,000 shares in an open-market transaction totaling about $7.13M under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited, short-lived negative drift versus peers unless follow-on selling continues or broader fundamentals change.

Evidence & confidence

The filing is a primary Form 4 disclosure with a sizable dollar value, yet it explicitly references a pre-arranged 10b5-1 plan, which typically dampens interpretation of insider intent.

Market effects

No direct sector read-through; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity needs rather than bearish expectations.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider sale; ticker VICR.

  • VINCIARELLI PATRIZIO

    Chairman & CEO and 10% owner who executed the open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VICRMed

VICR SWOT Analysis: Strong Revenue Growth and Patent Settlement

Vicor Corp (VICR) reported Q3 2026 revenue of $197.1M, up 78.5% YoY, driven by product sales and royalty revenue. Gross margin increased to 68.3%. The company has a strong order backlog of $406M but faces valuation concerns and customer concentration risks. It has growth opportunities in EVs and renewable energy. VICR's GF Score is 82/100, with high growth and profitability ratings but low valuation.

$VICRHigh

VICR Stock Surges On Blowout Q3 And Aggressive Capacity Bet

Vicor Corporation (VICR) stock rose 12.95% after reporting Q3 2026 revenue of $197.1M, up 78.5% YoY, with gross margin at 68.3%. The company's backlog and operating cash flow increased, driven by AI and high-performance systems demand. VICR is expanding capacity and faces an ITC investigation. Analysts raised price targets to $350-$360.

$VICRHighAI 8/10

Why is Vicor stock climbing today?

Vicor Corporation (VICR) stock rose 2.6% in morning trading, extending gains after its Q3 2026 earnings beat expectations. Revenue was $197.1M, up 78.5% YoY, with adjusted EPS of $1.33. Gross margin expanded to 68.3%, and the order backlog grew 166% YoY to $406M. Analysts maintained Buy ratings with price targets of $350 and $375. The stock traded at $209.36, above its 52-week low of $79 but below its high of $382.65.